Search research articles
Contact Us
Filters
Showing results (351-360 of 386) with videos related to
Page
of 39
Sort By:
Cancer Research
|
October 29, 2021
Heterogeneity of Circulating Tumor Cell-Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response
Nisha Kanwar, Zaldy Balde, Ranju Nair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2020
GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
Grainne M O'Kane, Barbara T Grünwald, Gun-Ho Jang, et al.
Nature Communications
|
November 14, 2018
Pathway-based subnetworks enable cross-disease biomarker discovery
Syed Haider, Cindy Q Yao, Vicky S Sabine, et al.
Breast Cancer Research and Treatment
|
June 23, 2025
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole
Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2024
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole
Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2022
Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
Grainne M O'Kane, Barbara T Grünwald, Gun-Ho Jang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 26, 2018
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer
David L Rimm, Samuel C Y Leung, Lisa M McShane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2020
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer
Joan M Romero, Barbara Grünwald, Gun-Ho Jang, et al.
Cancers
|
October 13, 2021
Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group
Mieke R Van Bockstal, Maxine Cooks, Iris Nederlof, et al.
British Journal of Cancer
|
October 11, 2012
Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials
H M Earl, L Hiller, J A Dunn, et al.
Page
of 39
Search research articles
Search
Showing results (351-360 of 386) with videos related to
Sort By:
Page
of 39
Cancer Research
|
October 29, 2021
Heterogeneity of Circulating Tumor Cell-Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response
Nisha Kanwar, Zaldy Balde, Ranju Nair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2020
GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
Grainne M O'Kane, Barbara T Grünwald, Gun-Ho Jang, et al.
Nature Communications
|
November 14, 2018
Pathway-based subnetworks enable cross-disease biomarker discovery
Syed Haider, Cindy Q Yao, Vicky S Sabine, et al.
Breast Cancer Research and Treatment
|
June 23, 2025
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole
Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2024
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole
Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2022
Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
Grainne M O'Kane, Barbara T Grünwald, Gun-Ho Jang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 26, 2018
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer
David L Rimm, Samuel C Y Leung, Lisa M McShane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2020
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer
Joan M Romero, Barbara Grünwald, Gun-Ho Jang, et al.
Cancers
|
October 13, 2021
Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group
Mieke R Van Bockstal, Maxine Cooks, Iris Nederlof, et al.
British Journal of Cancer
|
October 11, 2012
Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials
H M Earl, L Hiller, J A Dunn, et al.
Page
of 39